
### [NCIT:C3504](http://purl.obolibrary.org/obo/NCIT_C3504)
**Label:** Endometrial Disorder

**Subclasses:** [NCIT:C27850](http://purl.obolibrary.org/obo/NCIT_C27850) (Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells), [NCIT:C3504](http://purl.obolibrary.org/obo/NCIT_C3504) (Endometrial Disorder), [NCIT:C4894](http://purl.obolibrary.org/obo/NCIT_C4894) (Benign Endometrial Neoplasm), [NCIT:C4654](http://purl.obolibrary.org/obo/NCIT_C4654) (Atypical Endometrial Hyperplasia), [NCIT:C27815](http://purl.obolibrary.org/obo/NCIT_C27815) (Malignant Endometrial Neoplasm), [NCIT:C27838](http://purl.obolibrary.org/obo/NCIT_C27838) (Endometrial Serous Adenocarcinoma), [NCIT:C132294](http://purl.obolibrary.org/obo/NCIT_C132294) (Recurrent Endometrial Serous Adenocarcinoma), [NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma), [NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40144](http://purl.obolibrary.org/obo/NCIT_C40144) (Endometrial Mucinous Adenocarcinoma), [NCIT:C40145](http://purl.obolibrary.org/obo/NCIT_C40145) (Type I Endometrial Adenocarcinoma), [NCIT:C27839](http://purl.obolibrary.org/obo/NCIT_C27839) (Endometrial Endometrioid Adenocarcinoma, Secretory Variant), [NCIT:C8719](http://purl.obolibrary.org/obo/NCIT_C8719) (Endometrial Squamous Cell Carcinoma), [NCIT:C114656](http://purl.obolibrary.org/obo/NCIT_C114656) (Endometrial Adenosquamous Carcinoma), [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia), [NCIT:C7359](http://purl.obolibrary.org/obo/NCIT_C7359) (Endometrial Adenocarcinoma), [NCIT:C8942](http://purl.obolibrary.org/obo/NCIT_C8942) (Metastatic Endometrial Adenocarcinoma), [NCIT:C7558](http://purl.obolibrary.org/obo/NCIT_C7558) (Endometrial Carcinoma), [NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma), [NCIT:C8028](http://purl.obolibrary.org/obo/NCIT_C8028) (Endometrial Clear Cell Adenocarcinoma), [NCIT:C6287](http://purl.obolibrary.org/obo/NCIT_C6287) (Endometrial Endometrioid Adenocarcinoma), [NCIT:C27846](http://purl.obolibrary.org/obo/NCIT_C27846) (Villoglandular Endometrial Endometrioid Adenocarcinoma), [NCIT:C3012](http://purl.obolibrary.org/obo/NCIT_C3012) (Endometrial Neoplasm), [NCIT:C27844](http://purl.obolibrary.org/obo/NCIT_C27844) (Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component), [NCIT:C27845](http://purl.obolibrary.org/obo/NCIT_C27845) (Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component), [NCIT:C27789](http://purl.obolibrary.org/obo/NCIT_C27789) (Endometrial Intraepithelial Neoplasia), [NCIT:C27843](http://purl.obolibrary.org/obo/NCIT_C27843) (Endometrial Endometrioid Adenocarcinoma with Clear Cell Change), [NCIT:C6290](http://purl.obolibrary.org/obo/NCIT_C6290) (Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation), [NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma), [NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma), [NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma), [NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma), [NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma), [NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma), [NCIT:C39749](http://purl.obolibrary.org/obo/NCIT_C39749) (Type II Endometrial Adenocarcinoma), [NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma), [NCIT:C126772](http://purl.obolibrary.org/obo/NCIT_C126772) (Endometrial Large Cell Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C3504](http://purl.obolibrary.org/obo/NCIT_C3504) (Endometrial Disorder) 98.75%
- [NCIT:C3012](http://purl.obolibrary.org/obo/NCIT_C3012) (Endometrial Neoplasm) 95.00%
- [NCIT:C27815](http://purl.obolibrary.org/obo/NCIT_C27815) (Malignant Endometrial Neoplasm) 91.25%
- [NCIT:C7558](http://purl.obolibrary.org/obo/NCIT_C7558) (Endometrial Carcinoma) 90.00%
- [NCIT:C3504](http://purl.obolibrary.org/obo/NCIT_C3504) (Endometrial Disorder) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 90.00%
- [NCIT:C3012](http://purl.obolibrary.org/obo/NCIT_C3012) (Endometrial Neoplasm) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 90.00%
- [NCIT:C27815](http://purl.obolibrary.org/obo/NCIT_C27815) (Malignant Endometrial Neoplasm) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 90.00%
- [NCIT:C2916](http://purl.obolibrary.org/obo/NCIT_C2916) (Carcinoma) and [NCIT:C3504](http://purl.obolibrary.org/obo/NCIT_C3504) (Endometrial Disorder) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 90.00%
- [NCIT:C2916](http://purl.obolibrary.org/obo/NCIT_C2916) (Carcinoma) and [NCIT:C3012](http://purl.obolibrary.org/obo/NCIT_C3012) (Endometrial Neoplasm) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 90.00%
- [NCIT:C27815](http://purl.obolibrary.org/obo/NCIT_C27815) (Malignant Endometrial Neoplasm) and [NCIT:C2916](http://purl.obolibrary.org/obo/NCIT_C2916) (Carcinoma) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 90.00%
- [NCIT:C2916](http://purl.obolibrary.org/obo/NCIT_C2916) (Carcinoma) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 89.24%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 88.51%
- [NCIT:C3709](http://purl.obolibrary.org/obo/NCIT_C3709) (Epithelial Neoplasm) and [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 88.51%
- [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer) 87.81%
- [NCIT:C7359](http://purl.obolibrary.org/obo/NCIT_C7359) (Endometrial Adenocarcinoma) 81.25%


